Literature DB >> 15980595

Cyclic amplification of protein misfolding and aggregation.

Paula Saá1, Joaquín Castilla, Claudio Soto.   

Abstract

Diverse human disorders, including most neurodegenerative diseases, are thought to arise from the misfolding and aggregation of an underlying protein. We have recently described a novel technology to amplify cyclically the misfolding and aggregation process in vitro. This procedure, named protein misfolding cyclic amplification (PMCA), conceptually analogous to DNA amplification by PCR, has tremendous implications for research and diagnosis. The PMCA concept has been proved on the amplification of prions implicated in the pathogenesis of transmissible spongiform encephalopathies (TSE). In these diseases, there is a tremendous need for early and sensitive biochemical diagnosis to minimize the further spreading of the prion infectious agent through the food chain. In this chapter, we describe the principles behind the PMCA technology, its application, and methodology to detect minute quantities of misfolded prion protein and its potential to be used for amplification of misfolding of other proteins implicated in diverse diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980595     DOI: 10.1385/1-59259-874-9:053

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  37 in total

1.  Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Authors:  Shawn Browning; Christopher A Baker; Emery Smith; Sukhvir P Mahal; Maria E Herva; Cheryl A Demczyk; Jiali Li; Charles Weissmann
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Structure of the β2-α2 loop and interspecies prion transmission.

Authors:  Cyrus Bett; Natalia Fernández-Borges; Timothy D Kurt; Melanie Lucero; K Peter R Nilsson; Joaquín Castilla; Christina J Sigurdson
Journal:  FASEB J       Date:  2012-04-09       Impact factor: 5.191

3.  Cell-specific susceptibility to prion strains is a property of the intact cell.

Authors:  Maria E Herva; Charles Weissman
Journal:  Prion       Date:  2012-05-11       Impact factor: 3.931

Review 4.  In vitro studies of the transmission barrier.

Authors:  Natalia Fernández-Borges; Jorge de Castro; Joaquín Castilla
Journal:  Prion       Date:  2009-10-30       Impact factor: 3.931

Review 5.  Role of lipid in forming an infectious prion?

Authors:  Fei Wang; Jiyan Ma
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-04-12       Impact factor: 3.848

6.  Optimization of an amplification protocol for misfolded proteins by using relaxed control.

Authors:  Jean-Michel Coron; Pierre Gabriel; Peipei Shang
Journal:  J Math Biol       Date:  2014-02-25       Impact factor: 2.259

7.  Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions.

Authors:  Marcelo A Barria; Glenn C Telling; Pierluigi Gambetti; James A Mastrianni; Claudio Soto
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

8.  Production of cattle lacking prion protein.

Authors:  Jürgen A Richt; Poothappillai Kasinathan; Amir N Hamir; Joaquin Castilla; Thillai Sathiyaseelan; Francisco Vargas; Janaki Sathiyaseelan; Hua Wu; Hiroaki Matsushita; Julie Koster; Shinichiro Kato; Isao Ishida; Claudio Soto; James M Robl; Yoshimi Kuroiwa
Journal:  Nat Biotechnol       Date:  2006-12-31       Impact factor: 54.908

9.  Detection of infectious prions in urine.

Authors:  Dennisse Gonzalez-Romero; Marcelo A Barria; Patricia Leon; Rodrigo Morales; Claudio Soto
Journal:  FEBS Lett       Date:  2008-08-13       Impact factor: 4.124

10.  Prion strain discrimination in cell culture: the cell panel assay.

Authors:  Sukhvir P Mahal; Christopher A Baker; Cheryl A Demczyk; Emery W Smith; Christian Julius; Charles Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.